Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design

INTRODUCTION: Type 2 diabetes (T2DM) is associated with cardiovascular death, including sudden cardiac death due to arrhythmias. Patients with an implantable cardioverter-defibrillator (ICD) are also at high risk of developing a clinically significant ventricular arrhythmia. It has been reported tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiki, Shinya, Iijima, Kenichi, Okabe, Masaaki, Niwano, Shinichi, Tsujita, Kenichi, Naito, Shigeto, Ando, Kenji, Kusano, Kengo, Kato, Ritsushi, Nitta, Junichi, Miura, Tetsuji, Mitsuhashi, Takeshi, Kario, Kazuomi, Kondo, Yusuke, Ieda, Masaki, Hagiwara, Nobuhisa, Murohara, Toyoaki, Takahashi, Kazuyoshi, Tomita, Hirofumi, Takeishi, Yasuchika, Anzai, Toshihisa, Shimizu, Wataru, Watanabe, Masafumi, Morino, Yoshihiro, Kato, Takeshi, Tada, Hiroshi, Nakagawa, Yoshihisa, Yano, Masafumi, Maemura, Koji, Kimura, Takeshi, Yoshida, Hisako, Ota, Keiko, Tanaka, Takahiro, Kitamura, Nobutaka, Node, Koichi, Aizawa, Yoshifusa, Shimizu, Ippei, Izumi, Daisuke, Ozaki, Kazuyuki, Minamino, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547938/
https://www.ncbi.nlm.nih.gov/pubmed/32968947
http://dx.doi.org/10.1007/s13300-020-00924-9

Ejemplares similares

Ejemplares similares